Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1967 1
1970 1
1973 2
1974 3
1975 6
1976 2
1977 3
1978 7
1979 6
1980 15
1981 19
1982 21
1983 28
1984 32
1985 32
1986 30
1987 26
1988 27
1989 26
1990 50
1991 33
1992 52
1993 40
1994 55
1995 60
1996 53
1997 60
1998 62
1999 79
2000 101
2001 86
2002 76
2003 109
2004 122
2005 131
2006 148
2007 155
2008 181
2009 220
2010 228
2011 246
2012 312
2013 310
2014 306
2015 334
2016 317
2017 322
2018 352
2019 444
2020 377
2021 404
2022 323
2023 316
2024 122

Text availability

Article attribute

Article type

Publication date

Search Results

6,086 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Metastatic Lung Small Cell Carcinoma"
Page 1
Small-cell lung cancer.
Rudin CM, Brambilla E, Faivre-Finn C, Sage J. Rudin CM, et al. Nat Rev Dis Primers. 2021 Jan 14;7(1):3. doi: 10.1038/s41572-020-00235-0. Nat Rev Dis Primers. 2021. PMID: 33446664 Free PMC article. Review.
Small-cell lung cancer (SCLC) represents about 15% of all lung cancers and is marked by an exceptionally high proliferative rate, strong predilection for early metastasis and poor prognosis. SCLC is strongly associated with exposure to tobacco carcinog …
Small-cell lung cancer (SCLC) represents about 15% of all lung cancers and is marked by an exceptionally high pr …
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions.
Megyesfalvi Z, Gay CM, Popper H, Pirker R, Ostoros G, Heeke S, Lang C, Hoetzenecker K, Schwendenwein A, Boettiger K, Bunn PA Jr, Renyi-Vamos F, Schelch K, Prosch H, Byers LA, Hirsch FR, Dome B. Megyesfalvi Z, et al. CA Cancer J Clin. 2023 Nov-Dec;73(6):620-652. doi: 10.3322/caac.21785. Epub 2023 Jun 17. CA Cancer J Clin. 2023. PMID: 37329269 Free article. Review.
Small cell lung cancer (SCLC) is characterized by rapid growth and high metastatic capacity. ...Genomic profiling of SCLC reveals genetic instability, almost universal inactivation of the tumor suppressor genes TP53 and RB1, and a high mutation burden. …
Small cell lung cancer (SCLC) is characterized by rapid growth and high metastatic capacity. ...Genomic profilin …
Small-cell lung cancer.
van Meerbeeck JP, Fennell DA, De Ruysscher DK. van Meerbeeck JP, et al. Lancet. 2011 Nov 12;378(9804):1741-55. doi: 10.1016/S0140-6736(11)60165-7. Epub 2011 May 10. Lancet. 2011. PMID: 21565397 Review.
The incidence and mortality of small-cell lung cancer worldwide make this disease a notable health-care issue. ...Patients often present with rapid-onset symptoms due to local intrathoracic tumour growth, extrapulmonary distant spread, paraneoplastic syndrome …
The incidence and mortality of small-cell lung cancer worldwide make this disease a notable health-care issue. ...Patie …
Small-cell lung cancer brain metastasis: From molecular mechanisms to diagnosis and treatment.
Zhu Y, Cui Y, Zheng X, Zhao Y, Sun G. Zhu Y, et al. Biochim Biophys Acta Mol Basis Dis. 2022 Dec 1;1868(12):166557. doi: 10.1016/j.bbadis.2022.166557. Epub 2022 Sep 24. Biochim Biophys Acta Mol Basis Dis. 2022. PMID: 36162624 Free article. Review.
Lung cancer is the most malignant human cancer worldwide, also with the highest incidence rate. However, small-cell lung cancer (SCLC) accounts for 14 % of all lung cancer cases. ...
Lung cancer is the most malignant human cancer worldwide, also with the highest incidence rate. However, small-cell …
AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer.
Giffin MJ, Cooke K, Lobenhofer EK, Estrada J, Zhan J, Deegen P, Thomas M, Murawsky CM, Werner J, Liu S, Lee F, Homann O, Friedrich M, Pearson JT, Raum T, Yang Y, Caenepeel S, Stevens J, Beltran PJ, Canon J, Coxon A, Bailis JM, Hughes PE. Giffin MJ, et al. Clin Cancer Res. 2021 Mar 1;27(5):1526-1537. doi: 10.1158/1078-0432.CCR-20-2845. Epub 2020 Nov 17. Clin Cancer Res. 2021. PMID: 33203642
PURPOSE: Small-cell lung cancer (SCLC) is an aggressive neuroendocrine tumor with a high relapse rate, limited therapeutic options, and poor prognosis. ...AMG 757 effectively engaged systemically administered human T cells, induced T-cell activation, a …
PURPOSE: Small-cell lung cancer (SCLC) is an aggressive neuroendocrine tumor with a high relapse rate, limited therapeu …
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Ganti AKP, Loo BW, Bassetti M, Blakely C, Chiang A, D'Amico TA, D'Avella C, Dowlati A, Downey RJ, Edelman M, Florsheim C, Gold KA, Goldman JW, Grecula JC, Hann C, Iams W, Iyengar P, Kelly K, Khalil M, Koczywas M, Merritt RE, Mohindra N, Molina J, Moran C, Pokharel S, Puri S, Qin A, Rusthoven C, Sands J, Santana-Davila R, Shafique M, Waqar SN, Gregory KM, Hughes M. Ganti AKP, et al. J Natl Compr Canc Netw. 2021 Dec;19(12):1441-1464. doi: 10.6004/jnccn.2021.0058. J Natl Compr Canc Netw. 2021. PMID: 34902832 Free PMC article.
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Small Cell Lung Cancer (SCLC) provide recommended management for patients with SCLC, including diagnosis, primary treatment, surveillance for relapse, and subsequent treatment. This selec …
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Small Cell Lung Cancer (SCLC) provide recommend …
Signal pathways and precision therapy of small-cell lung cancer.
Yuan M, Zhao Y, Arkenau HT, Lao T, Chu L, Xu Q. Yuan M, et al. Signal Transduct Target Ther. 2022 Jun 15;7(1):187. doi: 10.1038/s41392-022-01013-y. Signal Transduct Target Ther. 2022. PMID: 35705538 Free PMC article. Review.
Small-cell lung cancer (SCLC) encounters up 15% of all lung cancers, and is characterized by a high rate of proliferation, a tendency for early metastasis and generally poor prognosis. ...Currently, there are six types of potential treatable signaling …
Small-cell lung cancer (SCLC) encounters up 15% of all lung cancers, and is characterized by a high rate of prol …
Mechanisms of small cell lung cancer metastasis.
Ko J, Winslow MM, Sage J. Ko J, et al. EMBO Mol Med. 2021 Jan 11;13(1):e13122. doi: 10.15252/emmm.202013122. Epub 2020 Dec 9. EMBO Mol Med. 2021. PMID: 33296145 Free PMC article. Review.
However, the molecular and cellular mechanisms underlying the ability of cancer cells to metastasize remain relatively poorly understood. Among all solid tumors, small cell lung cancer (SCLC) has remarkable metastatic proclivity, with a majority of pat …
However, the molecular and cellular mechanisms underlying the ability of cancer cells to metastasize remain relatively poorly understood. Am …
Small-cell lung cancer: what we know, what we need to know and the path forward.
Gazdar AF, Bunn PA, Minna JD. Gazdar AF, et al. Nat Rev Cancer. 2017 Dec;17(12):725-737. doi: 10.1038/nrc.2017.87. Epub 2017 Oct 27. Nat Rev Cancer. 2017. PMID: 29077690 Review.
Small-cell lung cancer (SCLC) is a deadly tumour accounting for approximately 15% of lung cancers and is pathologically, molecularly, biologically and clinically very different from other lung cancers. ...The probable initiating molecular events …
Small-cell lung cancer (SCLC) is a deadly tumour accounting for approximately 15% of lung cancers and is patholo …
Progress and prospects of early detection in lung cancer.
Blandin Knight S, Crosbie PA, Balata H, Chudziak J, Hussell T, Dive C. Blandin Knight S, et al. Open Biol. 2017 Sep;7(9):170070. doi: 10.1098/rsob.170070. Open Biol. 2017. PMID: 28878044 Free PMC article. Review.
It is broadly divided into small cell (SCLC, approx. 15% cases) and non-small cell lung cancer (NSCLC, approx. 85% cases). The main histological subtypes of NSCLC are adenocarcinoma and squamous cell carcinoma, with the presence of …
It is broadly divided into small cell (SCLC, approx. 15% cases) and non-small cell lung cancer (NSCLC, ap …
6,086 results